Vanesa G. Martínez

miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity

Keith O’Brien, Michelle C. Lowry, Claire Corcoran et al. · Oncotarget · 2015 · 268 citations · Full text

Resistance to HER2-targeted anti-cancer drugs is associated with immune evasion in cancer cells and their derived extracellular vesicles

Vanesa G. Martínez, Sadhbh O’Neill, Josephine Salimu et al. · OncoImmunology · 2017 · 131 citations · Full text

Filamin B Plays a Key Role in Vascular Endothelial Growth Factor-induced Endothelial Cell Motility through Its Interaction with Rac-1 and Vav-2

Beatriz del Valle‐Pérez, Vanesa G. Martínez, Cristina Lacasa-Salavert et al. · Journal of Biological Chemistry · 2010 · 99 citations · Full text

2-Deoxy-D-Glucose inhibits aggressive triple-negative breast cancer cells by targeting glycolysis and the cancer stem cell phenotype

Sadhbh O’Neill, Richard K. Porter, Niamh McNamee et al. · Scientific Reports · 2019 · 96 citations · Full text

CYP1B1 expression is induced by docetaxel: effect on cell viability and drug resistance

Vanesa G. Martínez, Robert O’Connor, Y Liang et al. · British Journal of Cancer · 2008 · 79 citations · Full text

Cellular Pharmacology, Pharmacotherapy, Cancer Biology +18